HEALTH & WEALTH

Clinical trials: What to know before you invest | Health & Wealth #9

When developing new therapies or medicines, there are many hurdles along the way to reaching the market. If you do, that is. Failure is lurking at every step. A drug candidate must be safe and have efficacy in patients without severe side effects. The risks are significant and so are the costs, but if a project is successful the reward could be enormous.

So, how to assess the risks involved correctly?

In this episode of Health & Wealth Jesper Prior Larsen from Aixial Group, leading experts at clinical trials, walks us through some of the things you need to be aware of before investing in life science.

YouTube video

BIOSTOCK STUDIO

BioStock Investor Pitch: Biosergen – vd Tine Kold Olesen 

BioStock Investor Pitch: Biosergen

I BioStock Studio berättar svenska Biosergen om sin vision, marknadsplan och strategi för att ta sin produkt genom den första patientstudien och vidare mot...

REKOMMENDERAD LÄSNING

Cline cartilage damage

Vetenskaplig rådgivare om potentialen i Clines cellterapi mot broskskador

Cline Scientific utvecklar en stamcellsbaserad behandling av tidiga broskskador för att undvika utveckling av...
BioStock Investor Pitch med Kancera, presenterad av vd Peter Selin

BioStock Investor Pitch: Kancera

Efter vinterns positiva fas IIa-resultat i hjärtinfarkt genomför Kancera en företrädesemission om 122 Mkr...